Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026)

Repligen (RGEN) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $2.9 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 2.76% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 billion (up 2.88% YoY) and the FY2025 annual result came in at $2.9 billion, up 4.24% from the prior year.
• Liabilities and Shareholders Equity slipped to $2.9 billion in Q1 2026 per RGEN's latest filing, from $2.9 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.9 billion in Q4 2025 and bottomed at $2.4 billion in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $2.8 billion (2024), against an average of $2.7 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity gained 23.69%; it then retreated 0.05% in 2025.
• Tracing RGEN's Liabilities and Shareholders Equity over 5 years: stood at $2.5 billion in 2022, then increased by 11.83% to $2.8 billion in 2023, then declined by 0.05% to $2.8 billion in 2024, then increased by 4.24% to $2.9 billion in 2025, then fell by 0.64% to $2.9 billion in 2026.
• Per Business Quant, the three latest RGEN Liabilities and Shareholders Equity figures stand at $2.9 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025).

Peer Comparison